PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
September 24, 2021Frontiers in Physiology6 citationsOpen Access

Spatial Changes in the Atrial Fibrillation Wave-Dynamics After Using Antiarrhythmic Drugs: A Computational Modeling Study

IHInseok HwangZJZe JinJPJe‐Wook Park

Structured PICO

Do antiarrhythmic drugs alter the spatial wave-dynamics (dominant frequency and its coefficient of variation) in a computational model of atrial fibrillation?

P
Population
Realistic computational modeling of 25 atrial fibrillation patients (68% male, 59.8 ± 9.8 years old, 32.0% paroxysmal AF) reflecting the anatomy, histology, and electrophysiology of the left atrium
I
Intervention
Five antiarrhythmic drugs (amiodarone, sotalol, dronedarone, flecainide, and propafenone) evaluated in a computational model
O
Outcome
Spatial change in the AF wave-dynamics measured by mean dominant frequency (DF) and its coefficient of variation (DF-COV) in 10 segments of the left atriumsurrogate

Computational modeling demonstrates that antiarrhythmic drugs reduce dominant frequency predominantly in the pulmonary veins, leading to AF termination or defragmentation under spatially unstable conditions.

Abstract

Background: We previously reported that a computational modeling-guided antiarrhythmic drug (AAD) test was feasible for evaluating multiple AADs in patients with atrial fibrillation (AF). We explored the anti-AF mechanisms of AADs and spatial change in the AF wave-dynamics by a realistic computational model. Methods: We used realistic computational modeling of 25 AF patients (68% male, 59.8 ± 9.8 years old, 32.0% paroxysmal AF) reflecting the anatomy, histology, and electrophysiology of the left atrium (LA) to characterize the effects of five AADs (amiodarone, sotalol, dronedarone, flecainide, and propafenone). We evaluated the spatial change in the AF wave-dynamics by measuring the mean dominant frequency (DF) and its coefficient of variation dominant frequency-coefficient of variation (DF-COV) in 10 segments of the LA. The mean DF and DF-COV were compared according to the pulmonary vein (PV) vs. extra-PV, maximal slope of the restitution curves (Smax), and defragmentation of AF. Results: The mean DF decreased after the administration of AADs in the dose dependent manner ( p 0.001). Under AADs, the DF was significantly lower ( p 0.001) and COV-DF higher ( p = 0.003) in the PV than extra-PV region. The mean DF was significantly lower at a high Smax (≥1.4) than a lower Smax condition under AADs. During the episodes of AF defragmentation, the mean DF was lower ( p 0.001), but the COV-DF was higher ( p 0.001) than that in those without defragmentation. Conclusions: The DF reduction with AADs is predominant in the PVs and during a high Smax condition and causes AF termination or defragmentation during a lower DF and spatially unstable (higher DF-COV) condition.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Hwang et al. (2021) studied this question.

synapsesocial.com/papers/6a1bcf390a1f7575939cf704https://doi.org/10.3389/fphys.2021.733543
Ask AI
Helpful
Bookmark
Share
View Full Paper